Cargando…

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease

Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota. This study aimed to compare the microbiota composition in h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ping-Hsun, Liu, Po-Yu, Chiu, Yi-Wen, Hung, Wei-Chun, Lin, Yi-Ting, Lin, Ting-Yun, Hung, Szu-Chun, Delicano, Rachel Ann, Kuo, Mei-Chuan, Wu, Chun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767080/ https://www.ncbi.nlm.nih.gov/pubmed/33419265 http://dx.doi.org/10.3390/microorganisms8122040

Ejemplares similares

Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
por: Wu, Mei-Yi, et al.
Publicado: (2017)

Ferric Citrate Hydrate as a Phosphate Binder and Risk of Aluminum Toxicity
por: Gupta, Ajay
Publicado: (2014)

Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
por: Lin, Yi-Ting, et al.
Publicado: (2021)

Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers
por: Lin, Yi-Ting, et al.
Publicado: (2021)

Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model
por: Brunelli, Steven M., et al.
Publicado: (2017)

Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
por: Rodby, Roger A., et al.
Publicado: (2015)

Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”
por: Rascati, Karen
Publicado: (2017)

Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial
por: Lee, Chien-Te, et al.
Publicado: (2022)

The fciTABC and feoABI systems contribute to ferric citrate acquisition in Stenotrophomonas maltophilia
por: Liao, Chun-Hsing, et al.
Publicado: (2022)

Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021)

Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study
por: Wu, Ping-Hsun, et al.
Publicado: (2020)

Antiviral effects of ferric ammonium citrate
por: Wang, Hongbin, et al.
Publicado: (2018)

Physicochemical characterization of ferric pyrophosphate citrate
por: Gupta, Ajay, et al.
Publicado: (2018)

Ferric pyrophosphate citrate: interactions with transferrin
por: Pratt, Raymond, et al.
Publicado: (2018)

Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients
por: Lin, Hsin-Hung, et al.
Publicado: (2016)

Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies
por: Wang, Lin-Chun, et al.
Publicado: (2021)

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2012)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

The Ferric Citrate Uptake System Encoded in a Novel bla(CTX–M–3)- and bla(TEM–1)-Harboring Conjugative Plasmid Contributes to the Virulence of Escherichia coli
por: Huang, Wen-Chun, et al.
Publicado: (2021)

Multiple Hypovascular Tumors in Kidney: A Rare Case Report and Differential Diagnosis
por: Wu, Pei-Yu, et al.
Publicado: (2013)

Comparative Gut Microbiome Differences between High and Low Aortic Arch Calcification Score in Patients with Chronic Diseases
por: Liu, Yi-Hsueh, et al.
Publicado: (2023)

Mechanism of Action and Clinical Attributes of Auryxia(®) (Ferric Citrate)
por: Ganz, Tomas, et al.
Publicado: (2019)

The demise of calcium-based phosphate binders—is this appropriate for children?
por: Rees, Lesley, et al.
Publicado: (2014)

Predicting Mortality of Incident Dialysis Patients in Taiwan - A Longitudinal Population-Based Study
por: Wu, Ping-Hsun, et al.
Publicado: (2013)

High Cost and Low Survival Rate in High Comorbidity Incident Elderly Hemodialysis Patients
por: Lin, Yi-Ting, et al.
Publicado: (2013)

A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
por: Hanudel, Mark R., et al.
Publicado: (2022)

Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
por: Chait, Yossi, et al.
Publicado: (2022)

Comparison of dementia risk between end stage renal disease patients with hemodialysis and peritoneal dialysis - a population based study
por: Lin, Yi-Ting, et al.
Publicado: (2015)

The Interaction of miR-378i-Skp2 Regulates Cell Senescence in Diabetic Nephropathy
por: Tsai, Yi-Chun, et al.
Publicado: (2018)

Geriatric Nutritional Risk Index Is Associated with Unique Health Conditions and Clinical Outcomes in Chronic Kidney Disease Patients
por: Lin, Ting-Yun, et al.
Publicado: (2019)

Reduction of costs for anemia-management drugs associated with the use of ferric citrate
por: Thomas, Anila, et al.
Publicado: (2014)

Ferric citrate controls serum phosphorus in dialysis patients: retrospective data
por: Hain, Debra J., et al.
Publicado: (2017)

Ferric citrate is a safe and digestible source of iron in broilers and piglets
por: Männer, Klaus, et al.
Publicado: (2021)

Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli
por: Frick-Cheng, Arwen E., et al.
Publicado: (2022)

Fluid Overload, Pulse Wave Velocity, and Ratio of Brachial Pre-Ejection Period to Ejection Time in Diabetic and Non-Diabetic Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2014)

Using a Short Food Frequency Questionnaire to Evaluate Macronutrients, Fiber, Phosphorus, Potassium, and Calcium in Adults with Stages 3–5 Chronic Kidney Disease
por: Huang, Meng-Chuan, et al.
Publicado: (2022)

Urine pH and Citrate as Predictors of Calcium Phosphate Stone Formation
por: Adomako, Emmanuel A., et al.
Publicado: (2023)

A Low Ankle-Brachial Index and High Brachial-Ankle Pulse Wave Velocity Are Associated with Poor Cognitive Function in Patients Undergoing Hemodialysis
por: Wu, Ping-Hsun, et al.
Publicado: (2019)

Angpt2 Induces Mesangial Cell Apoptosis through the MicroRNA-33-5p-SOCS5 Loop in Diabetic Nephropathy
por: Tsai, Yi-Chun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p18p8p626patnk0p9fc38ia3ol